For example, in oesophageal cancer, research has revealed that the MALR binds to the dsRBD1 domain of interleukin enhancer-binding factor 3 (ILF3), thereby enhancing the stability of ILF3 protein. This evidence concerns the gene ILF3 and carcinoma of esophagus.